jain.com
The Analysis · Companies · People · Methodology

Nasdaq listing approval and trading commencement date

Company: IREN

This claim was marked delayed on September 15, 2026. Recorded automatically from the cited source when it was published, then queued for evidence review.

How this was decided: Automated extraction from the cited source. The claim is preserved below exactly as it was originally published, so the record shows what was asserted as well as what became of it.

Subject kind
regulatory
Statement date
2021-11-17
Promised by
2021-11-17
Current status
delayed

The claim, verbatim

Ordinary shares approved for listing on Nasdaq Global Select Market under symbol IREN; expected to begin trading on or about November 17, 2021

Source (primary)

IREN 424B4 filed 2021-11-18 (SEC EDGAR, sec_filing)
View cached copy (2026-09-13)Live source ↗

Quote: “Our Ordinary shares have been approved for listing on the Nasdaq Global Select Market ("Nasdaq") under the symbol "IREN". We expect our Ordinary shares to begin trading on or about November 17, 2021”

How we checked this

This claim has not yet been checked assertion-by-assertion against its source. It carries a cited source and quote, but the deeper check has not run. When it does, the result appears here whatever it says.

Additional evidence

confirms IREN 424B4 filed 2021-11-18

Quote: “Our Ordinary shares have been approved for listing on the Nasdaq Global Select Market ("Nasdaq") under the symbol "IREN". We expect our Ordinary shares to begin trading on or about November 17, 2021”

View cached copy (2026-09-13)Live source ↗

Record of changes

September 14, 2026 — stated
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.
September 15, 2026 — delayed
Automated extraction from the cited source. Recorded automatically from the cited source when it was published, then queued for evidence review.